Dublin, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/7pqrzp/digital_pathology) has announced the addition of the "Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Global Forecasts & Trends to 2018" report to their offering.
The demand for digital pathology is growing and is expected to continue to rise in the coming years as well. The use of scanners and image analysis software enable pathologists to be efficient and this leads to improved quality care for patients.
In 2013, the North American market was valued at $128.9 million and accounted for the largest share of the global digital pathology market, followed by Europe and Asia. The North American market is expected to grow at a healthy growth rate over the next five years.
This high growth can be attributed to the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, lack of FDA approvals for digital pathology to be used for primary diagnosis acts as a major barrier for the North American market.
The European region has gained momentum for digital pathology. Some of the European countries have witnessed successful pathology projects which are likely to lead to higher adoption of digital pathology in these countries. Furthermore, Europe hosts various digital pathology conferences that aim to bring professionals under one roof and bring to light the ongoing developments in digital pathology.
However, the Asian market, slated at an estimated CAGR of 13.7%, will experience the highest growth in the digital pathology market. The rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the use of digital pathology to improve the quality of cancer diagnosis are some of the factors driving the growth of the Asian market.
The global digital pathology market was valued at an estimated $250.2 million in 2013 and is expected to grow at a CAGR of 11.8%, to reach an estimated $437 million by 2018.
The major players in this market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.).
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Digital Pathology: Rationale for Adoption
5 Global Digital Pathology Market, By Product
6 Global Digital Pathology Market, By Application
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles
- 3dhistech Ltd.
- Apollo Pacs, Inc.
- Aurora Interactive Ltd.
- Corista LLC
- Definiens AG
- Digipath, Inc.
- Hamamatsu Photonics K.K.
- Huron Technologies International, Inc.
- Indica Labs, Inc.
- Kanteron Systems
- Leica Biosystems, Gmbh
- Ligolab, LLC
- Mikroscan Technologies, Inc.
- Nikon Instruments, Inc.
- Objective Pathology Services, Ltd.
- Omnyx, LLC
- Pathxl, Ltd.
- Pixcelldata, Ltd.
- Sunquest Information Systems, Inc.
- Ventana Medical Systems, Inc.
- Xifin, Inc.
For more information visit http://www.researchandmarkets.com/research/7pqrzp/digital_pathology
CONTACT: Research and Markets Laura Wood, Senior Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Medical Devices
Source:Research and Markets